| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Jounce Therapeutics, Inc. | Director | Common Stock | 50,468 | $93,366 | $1.85 | 12 Nov 2021 | Direct |
| Jounce Therapeutics, Inc. | Director | Common Stock | 0 | $1.85 | 12 Nov 2021 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924321044914-pfeffer-cary-2021-11-12 | Jounce Therapeutics, Inc. | 12 Nov 2021 | 1 | $0 | 4 | Director | 16 Nov 2021, 18:54 |
| /report/000089924321036399-pfeffer-cary-2021-09-15 | Jounce Therapeutics, Inc. | 15 Sep 2021 | 1 | $0 | 4 | Director | 17 Sep 2021, 13:38 |
| /report/000164045521000114-pfeffer-cary-2021-06-18 | Jounce Therapeutics, Inc. | 18 Jun 2021 | 1 | $0 | 4 | Director | 22 Jun 2021, 16:49 |
| /report/000089924321023559-pfeffer-cary-2021-06-10 | Jounce Therapeutics, Inc. | 10 Jun 2021 | 1 | $0 | 4 | Director | 14 Jun 2021, 16:23 |